Riskpilot← Back to searchSign inGet full accessOftalmed AB
ABActiveOrg 5592297559Storgatsbacken 9Temporary employment agency activities and other human resource provisions · NACE 7820Est. 201910-19 employees
Revenue 2025
SEK 22,5M
+317% vs 2024
EBITDA margin
25.4%
+760% vs 2024
Equity ratio
40.9%
Financial strength
Net profit 2025
SEK 3,1M
+12156% vs 2024
| Revenue | SEK 22,5M | +317% |
| EBITDA | SEK 5,7M | +760% |
| Net profit | SEK 3,1M | +12156% |
| Total assets | SEK 13,8M | +36% |
| Equity | SEK 5,7M | +77% |
| Employees | — | — |
Legal name
Oftalmed AB
Org number
5592297559
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
4 december 2019
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva sjukvård, företagshälsovård, uthyrning av personal samt medieproduktion samt bedriva handel med värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Storgatsbacken 9
Email
info@ogoncenter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 843 | 4 787 | 5 563 | 5 387 | 22 487 |
| Staff expenses | — | −2 009 | −2 420 | — | −7 443 |
| EBITDA | 3 329 | 2 981 | 3 060 | −866 | 5 718 |
| Depreciation & amort. | −0 | −3 | −72 | −449 | −821 |
| EBIT | 3 329 | 2 978 | 2 989 | −1 315 | 4 897 |
| Net financials | — | −1 | 52 | 27 | −175 |
| Profit before tax | 2 504 | 2 238 | 2 108 | 81 | 3 872 |
| Tax | −536 | −462 | −460 | −56 | −808 |
| Net profit | 1 968 | 1 775 | 1 648 | 25 | 3 064 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 778 | 5 791 | 7 574 | 10 189 | 13 837 |
| Equity | 2 990 | 3 358 | 4 206 | 3 200 | 5 665 |
| Long-term debt | 0 | — | — | 3 863 | 3 413 |
| Short-term debt | 480 | 386 | 389 | 1 515 | 2 298 |
| Total debt | 480 | 386 | 389 | 5 378 | 5 710 |
EBITDA margin
25.4%
This company
15.8%
Market median
+61% vs market
20212025
Equity ratio
40.9%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
54.1%
This company
18.4%
Market median
+194% vs market
20212025
Net profit margin
13.6%
This company
8.1%
Market median
+68% vs market
20212025
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20212025
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SC | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oftalmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanna Catrine Sandberg | Audit | 0 companies |
| Erika Alexandra Marie Kassem | Deputy Board Member | 0 companies |
| Amin-Robert Kassem | Board of Directors | 0 companies |
| Ahmad Ali Kassem | Deputy Board Member | 0 companies |